Press Releases

MedAI Releases Drug Formulation Development Service for the Pharmaceutical Industry

UK Healthcare Pavilion brings Together the UK’s Healthcare and Life Sciences Sector for The First Time

The UK Healthcare Pavilion has launched a new virtual platform to bring together life sciences companies, hospitals, clinics, and key organisations — helping global customers discover, connect and innovate.

BOC Sciences Launched Its E3 Ubiquitin Ligase Activity Assay Services to Assist PROTAC Drug Development

Alfa Chemistry: T,C&A Lab Unveils Ingredient Analysis Service

Creative Biogene: The Premier Institution Providing Neurodegenerative Diseases Diagnostic Kits

Atik Cameras Supports the COVID-19 Fight with Wide Range of Advanced Imaging Solutions for Use with PCR Instruments

Atik Cameras, a specialist designer and manufacturer of advanced scientific imaging solutions, has further expanded its collaboration with leading global Original Equipment Manufacturers (OEMs) of real time Polymerase Chain Reaction (PCR) DNA amplifiers, securing multiple new contracts to supply high-performing cameras for reliable COVID-19 testing.

Quinten spins off 50 data scientists to become a global leader in precision care using artificial intelligence and real-world data science

Quinten, a pioneer in AI-powered decision support solutions, has launched Quinten Health — a global and integrated analytical services and tools development offer.

Immudex launches dCODE Dextramer® (RiO), a new reagent compatible with BD Rhapsody™ Single Cell Analysis system

Immudex ApS, the sole proprietor of DNA barcoded MHC multimer technology, has announced the launch of dCODE Dextramer® (RiO) — a new reagent compatible with BD Rhapsody™ Single Cell Analysis system for multiplexing, allowing the identification of many different T-cell specificities in the same sample. Creating personalized dCODE Dextramer® libraries, is possible to profile T cells and get a new understanding of T-cell immunity.

VERICHEM LABORATORIES EXPANDS REPORT OPTIONS FOR ITS FREE CLIA COMPLIANT CALIBRATION VERIFICATION PROGRAM

VERICHEM LABORATORIES has announced that it has expanded the available test reporting options that it offers with its Calibration Verification Data Reduction Program.

Albumedix enters into collaboration agreement with Cell and Gene Therapy Catapult

Albumedix Ltd., the world leader in recombinant human albumin, has entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult), an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.

Bio-Rad’s Multi-Target Reliance SARS-CoV-2/FluA/FluB RT-PCR and Reliance SARS-CoV-2 RT-PCR Assay Kits Granted FDA Emergency Use Authorization

Bio-Rad Laboratories, Inc. announced that its Reliance SARS-CoV-2/FluA/FluB RT-PCR and Reliance SARS-CoV-2 RT-PCR Assay Kits were granted Emergency Use Authorization by the U.S. Food and Drug Administration.

BioIVT Unveils COVID-19 Panel to Accelerate Vaccine-generated Immune Response Research

The panel contains serum or peripheral blood mononuclear cells (PBMCs) isolated from pre- and post-vaccination blood samples.

Matexcel Introduced Mechanical Environment Reliability Test Worldwide

Lifeasible Developed Thermal Analysis Platform for Material Research

Lonza Announces High-Quality Cryopreserved Leukopaks for More Flexibility in Immunology and Cell Therapy Research

Lonza has expanded its renowned human primary cell offerings with the launch of fully customizable, high-quality cryopreserved Leukopaks to biopharmaceutical researchers across the globe. The frozen Leukopaks will enable long-distance shipping of leukapheresis products without the concern of reduced cell viability encountered with fresh Leukopaks, and will eliminate the risk and costs associated with donor cancellations or changes to experimental schedules.

ENPICOM introduces an end-to-end solution for fast and efficient antibody discovery

ENPICOM BV, an innovative bioinformatics software engineering company, has announced the release of its ImmunoGenomiX (IGX) Platform featuring the new Antibody Discovery Module. The IGX Platform is a professional tool to manage, analyze, integrate, and visualize immune repertoire sequencing data in a single environment. This solution will allow scientists in biopharmaceutical companies and academia, as well as service providers working in the antibody discovery field, to make the most of their Sanger and NGS data and independently perform complex analyses.

Alfa Chemistry Recently Launched a Sub-website for Functional Polymers

Alfa Chemistry Launches MOF Chemicals for the Science Community

Syntekabio and Hanmi Science Join Forces to Co-Develop New Promising COVID-19 Treatments Using Drug Repurposing Technologies

Syntekabio has announced a strategic collaboration with Hanmi Science to co-develop breakthrough COVID-19 treatments using drug repositioning technologies.

MedAI Launches Artificial Intelligence Drug Discovery (AIDD) Platform to Accelerate Drug Development

To accelerate drug development, MedAI, an expert of AI-assisted R&D research company, announces that it has completed the construction of its Artificial Intelligence Drug Discovery (AIDD) Platform. With this platform, scientists at MedAI are now capable of providing innovative solutions for pharmaceutical companies to push forward their drug discovery projects.